Worst performer and only major faller was OPTI:Optibiotix which dropped 6p or 9%. That would have cost me £6,300 so it shows the other shares were up by £600. I guess the traders are taking their 10% from when they bought in the late 40's.
JLP:Jubilee Metals started to move again, climbing 6% and this is only 10% down now. The next production figures should see a re-rate.
MMX:Minds + Machines are also starting to motor, with a 9% climb this week meaning they are only 7% down altogether. I really hope they announce a dividend.
Share of the Week is IKA:Ilika which went up by 14% but is still 25% down. I think there's a feeling the car battery technology may pay off so folks are piling in. I'm still keen to pile out as I'm not convinced they have a clue about how to be commercial.
Blip or trend?
At least we're still pulling the trend line flatter.
Here's the performance of the ISA and share accounts
| Weekly Change | |||
| Cash | £15.74 | +£0 | |
| Portfolio cost | £57,768.95 | +£0 | |
| Portfolio sell value (bid price-commission) | £42,329.65 | (-26.7%) | -£3,034.00 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.63 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£35.78 | (-0.7%) | +£1.70 |
| Total Dividends | £1,342.93 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £402.44 | (8.4%) | -£1.76 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | 13.0% | +0% | |
| Compound performance | 57% | +0% |
Pretty much all of the drop is down to OPTI:Optibiotix, just one week after I was hoping to report that it was back in profit.
Every time is starts looking promising, down we go again.
Still on the right side of the trend line, but in a few weeks there will be nothing left in the black.
The SIPP looks like this after week 214
| Weekly Change | ||||
| Cash | £90.97 | +£0.01 | ||
| Portfolio cost | £46,995.31 | +£0 | ||
| Portfolio sell value (bid price - commission) |
£38,614.81 | (-17.8%) | -£2,694.21 | |
| Potential profits | £707.97 | +£60.00 | ||
| Yr 5 Dividends | £0 | +£0 | ||
| Yr 5 Interest | £0.01 | +£0.01 | ||
| Yr 5 Profit from sales | £0 | +£0 | ||
| Yr 5 Average monthly cash profit | -£8.92 | (-0.2%) | +£1.79 | |
| Total Dividends | £1,899.24 | +£0 | ||
| Total Interest | £0.18 | +£0.01 | ||
| Total Profit from sales | £12,549.10 | +£0 | ||
| Average monthly cash profit | £283.34 | (7.2%) | -£1.33 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Performance/Injection | 11.4% | +0% | ||
| Compound performance | 47% | +0% |
Similar story to the ISA, but at least CAML:Central Asia Metals climbed by £60 potential profits, and I spotted 1p interest earned in December - yippee!
Still just above halfway between the orange and red lines
I have almost 6 months before all the above zero values disappear.
The trading account looks like this after week 180
| Weekly Change | |||
| Cash | £48.24 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,282.80 | (-44.7%) | +£34.98 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £2.38 | (1.2%) | -£0.11 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.39 | (-0.2%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | -0.2% | +0% | |
| Compound performance | -1% | +0% |
Another reasonable week, with small increases in most of the shares. CAML:Central Asia Metals is now only 12% down, so there is a vague hope something could happen here.
Who am I trying to kid - this is still way down on just a few months ago.
Just above the trend line though
Here's the virtual magic formula account
| Weekly Change | |||
| Cash | £153.61 | +£0 | |
| Portfolio cost | £29,846.39 | +£0 | |
| Portfolio sell value (bid price - commission) | £30,920.30 | (+3.6%) | -£180.43 |
| Potential profits | £1,350.65 | -£180.81 | |
| Year 1 Dividends | £0 | +£0 | |
| Year 1 Profit | £0 | +£0 | |
| Yr 1 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £0 | +£0 | |
| Profit from sales | £0 | +£0 | |
| Average monthly cash profit | £0 | (0%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) |
Quite impressive that the reduction in value is accounted for by a reduction in paper profits down to just a few pence. Best performer is EVR:Evraz, up 12.21% since I "bought" them, and worst performer is BMN:Bushveld Minerals, down by 12.17%.
No updates for a few weeks now as I'm off on holiday, but I'll take weekly snapshots and do a big catch-up at the end of January. By then OPTI:Optibiotix will have issued a trading statement, SBTX:SkinBioTherapeutics may have announced their second deal, JLP:Jubilee Metals may have re-rated, MMX:Minds+Machines may have hinted at a dividend, and TALY:Tally may have lifted their suspension. We can but hope.
No comments:
Post a Comment